Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/28/2025

Management of Morning Nausea and Vomiting in Perimenopausal Women with Anxiety Symptoms

Diagnostic Approach

  • Evaluate whether symptoms follow a cyclical pattern or are triggered by stress/anxiety to distinguish between hormonal influence and psychological component 3
  • Rule out medication-induced nausea by checking blood levels of relevant medications if applicable, such as digoxin, phenytoin, carbamazepine, or tricyclic antidepressants 1

Treatment Algorithm

  • For predominantly anxiety-related morning nausea/vomiting, initiate a dopamine receptor antagonist, such as metoclopramide 5-10mg PO 30 minutes before breakfast, and add a benzodiazepine, such as lorazepam 0.5-1mg PO every 4-6 hours as needed, according to the National Comprehensive Cancer Network 1, 2
  • Consider morning dosing to target the specific timing of symptoms, as recommended by the National Comprehensive Cancer Network 4
  • For persistent symptoms, add a 5-HT3 receptor antagonist, such as ondansetron, if first-line treatment is insufficient, as suggested by the National Comprehensive Cancer Network 1
  • Consider adding an anticholinergic agent, such as scopolamine, and/or antihistamine, such as meclizine, for refractory symptoms, according to the National Comprehensive Cancer Network 1
  • For severe cases, add a corticosteroid, such as dexamethasone, as recommended by the National Comprehensive Cancer Network 1

Important Considerations and Pitfalls

  • Be cautious with long-term benzodiazepine use due to risk of dependence; consider short-term use while implementing other strategies, as advised by the National Comprehensive Cancer Network 1
  • Monitor for medication side effects, particularly with dopamine receptor antagonists which may cause extrapyramidal symptoms, according to the National Comprehensive Cancer Network 1
  • Consider opioid rotation if the patient is on opioids that may be contributing to nausea, as suggested by the National Comprehensive Cancer Network 1

REFERENCES

2

palliative care version 1.2016. [LINK]

Journal of the National Comprehensive Cancer Network : JNCCN, 2016

3

palliative care version 1.2016. [LINK]

Journal of the National Comprehensive Cancer Network : JNCCN, 2016

4

nccn clinical practice guidelines in oncology: palliative care. [LINK]

Journal of the National Comprehensive Cancer Network : JNCCN, 2009